Press release
Biliary Tract Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera
DelveInsight's "Biliary Tract Cancer Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Biliary Tract Cancer, historical and forecasted epidemiology as well as the Biliary Tract Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Biliary Tract Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Biliary Tract Cancer Market Forecast [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Biliary Tract Cancer Market Report:
* The Biliary Tract Cancer market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
* The overall number of BTC incident cases in the 7MM population in 2022 was found to be 38,000. Japan was the country with the highest number of cases of BTC cancer, followed by the US.
* Of the total number of stage-specific BTC cases in EU4 and the UK in 2022, around 89% were of Stage IV, compared to approximately 18% in Japan and approximately 37% in the US
* A total of approximately 16,000 BTC patients were treated in the US in 2022; 4,500 of these cases were localized and regional, 8,000 were first-line advanced or metastatic cases, and 3,000 were second-line and above advanced or metastatic cases.
* In Japan, around 45% of BTC patients were 80 years of age or older in 2022. In the US, about 24% of BTC patients were 80 years of age or older, and about 29% of patients were between the ages of 70 and 79.
* Key Biliary Tract Cancer Companies: Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Inc., Compass Therapeutics, Boehringer Ingelheim, ZielBio, Inc., GeneQuantum Healthcare (Suzhou) Co., Ltd., BioNTech SE, SOTIO Biotech, Carisma Therapeutics Inc, Rain Oncology Inc, Avacta Life Sciences Ltd, DualityBio Inc., and others
* Key Biliary Tract Cancer Therapies: Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, XmAb20717, Nivolumab + DKN-01, CTX-009, MEDI5752, Brigimadlin, ZB131, GQ1001, BNT141, SO-C101, CT-0508, RAIN-32, AVA6000, DB-1303, and others
* The Biliary Tract Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Biliary Tract Cancer pipeline products will significantly revolutionize the Biliary Tract Cancer market dynamics.
Biliary Tract Cancer Overview
Hepatocellular carcinoma (HCC), biliary tract cancer (BTC), and other metastatic illnesses are among the frequent malignant liver lesions. The following are examples of biliary tract cancer (BTC), which are epithelial malignancies of the biliary tree: Cholangiocarcinoma (CCA) and gallbladder cancer (GBC).
Get a Free sample for the Biliary Tract Cancer Market Report:
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market [https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Biliary Tract Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Biliary Tract Cancer Epidemiology Segmentation:
The Biliary Tract Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
* Total Prevalence of Biliary Tract Cancer
* Prevalent Cases of Biliary Tract Cancer by severity
* Gender-specific Prevalence of Biliary Tract Cancer
* Diagnosed Cases of Episodic and Chronic Biliary Tract Cancer
Download the report to understand which factors are driving Biliary Tract Cancer epidemiology trends @ Biliary Tract Cancer Epidemiology Forecast [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Biliary Tract Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Biliary Tract Cancer market or expected to get launched during the study period. The analysis covers Biliary Tract Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Biliary Tract Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Biliary Tract Cancer Therapies and Key Companies
* Keytruda (pembrolizumab): Merck Sharp & Dohme
* Imfinzi (durvalumab): AstraZeneca
* Futibatinib (TAS-120): Taiho Oncology
* Melphalan: Delcath Systems
* E7090 (tasurgratinib): Eisai
* TT-00420: TransThera Sciences (Nanjing)
* ARQ 087 (Derazantinib): Basilea Pharmaceutica
* Lenvima (lenvatinib): Eisai and Merck & Co
* Zanidatamab: Zymeworks and BeiGene
* XmAb20717: Xencor, Inc.
* Nivolumab + DKN-01: Bristol-Myers Squibb/Leap Therapeutics, Inc.
* CTX-009: Compass Therapeutics
* MEDI5752: AstraZeneca
* Brigimadlin: Boehringer Ingelheim
* ZB131: ZielBio, Inc.
* GQ1001: GeneQuantum Healthcare (Suzhou) Co., Ltd.
* BNT141: BioNTech SE
* SO-C101: SOTIO Biotech
* CT-0508: Carisma Therapeutics Inc
* RAIN-32: Rain Oncology Inc
* AVA6000: Avacta Life Sciences Ltd
* DB-1303: DualityBio Inc.
Discover more about therapies set to grab major Biliary Tract Cancer market share @ Biliary Tract Cancer Treatment Market [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Biliary Tract Cancer Market Strengths
* The therapeutic landscape in BTCs has expanded considerably in recent years. Combined therapy with chemotherapy, immunotherapy, and modulation of immune checkpoints-mediated signaling pathways are promising strategies.
Biliary Tract Cancer Market Opportunities
* Increasing cognizance about different mutations, pathways, and other regimens has changed the focus on curable treatment options with emerging candidates that will lead the growth of the global market.
Scope of the Biliary Tract Cancer Market Report
* Study Period: 2020-2034
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Biliary Tract Cancer Companies: Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Inc., Compass Therapeutics, Boehringer Ingelheim, ZielBio, Inc., GeneQuantum Healthcare (Suzhou) Co., Ltd., BioNTech SE, SOTIO Biotech, Carisma Therapeutics Inc, Rain Oncology Inc, Avacta Life Sciences Ltd, DualityBio Inc., and others
* Key Biliary Tract Cancer Therapies: Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, XmAb20717, Nivolumab + DKN-01, CTX-009, MEDI5752, Brigimadlin, ZB131, GQ1001, BNT141, SO-C101, CT-0508, RAIN-32, AVA6000, DB-1303, and others
* Biliary Tract Cancer Therapeutic Assessment: Biliary Tract Cancer current marketed and Biliary Tract Cancer emerging therapies
* Biliary Tract Cancer Market Dynamics: Biliary Tract Cancer market drivers and Biliary Tract Cancer market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Biliary Tract Cancer Unmet Needs, KOL's views, Analyst's views, Biliary Tract Cancer Market Access and Reimbursement
To know more about Biliary Tract Cancer companies working in the treatment market, visit @ Biliary Tract Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Biliary Tract Cancer Market Report Introduction
2. Executive Summary for Biliary Tract Cancer
3. SWOT analysis of Biliary Tract Cancer
4. Biliary Tract Cancer Patient Share (%) Overview at a Glance
5. Biliary Tract Cancer Market Overview at a Glance
6. Biliary Tract Cancer Disease Background and Overview
7. Biliary Tract Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Biliary Tract Cancer
9. Biliary Tract Cancer Current Treatment and Medical Practices
10. Biliary Tract Cancer Unmet Needs
11. Biliary Tract Cancer Emerging Therapies
12. Biliary Tract Cancer Market Outlook
13. Country-Wise Biliary Tract Cancer Market Analysis (2020-2034)
14. Biliary Tract Cancer Market Access and Reimbursement of Therapies
15. Biliary Tract Cancer Market Drivers
16. Biliary Tract Cancer Market Barriers
17. Biliary Tract Cancer Appendix
18. Biliary Tract Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=biliary-tract-cancer-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20232032-states-delveinsight-astrazeneca-taiho-oncology-delcath-systems-transthera]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biliary Tract Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera here
News-ID: 3457234 • Views: …
More Releases from ABNewswire
Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Biliary
Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of…
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market?
The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which…
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
